Dr Curcio is the author of Current Rational to Prescribe Tigecycline: Critical Analysis of the Evidence and Usage Algorithms by an Argentinean Experts Panel and Tigecycline in the Treatment of Community-Acquired Pneumonia which were recently published in Clinical Medicine Insights: Therapeutics.

The Editor in Chief of Clinical Medicine Insights: Therapeutics recently issued a call for papers.

Please describe your experience with Libertas Academica:

I´m very pleased to publish my article with Libertas Academica. My article was about a very important consensus about the tigecycline use in Argentina and the rational to use this antibiotic in community-acquired pneumonia. I consider that both are very useful for all the Latin American physicians. In addition, the possibility to download the article without charge is an important issue in our region.

What is the primary focus of your research?

Antibiotic use in hospitalized patients.

What are the most exciting developments arising from current research in your area?

The development of antibiotic stewardship programs, mainly in hospitals with limited resources.

Who are your main collaborators? Please describe your work with them.

Ariel Hernán Curiale. He developed all the informatic support to collect the data and the statistical analysis of my papers.

How did you come to be working in your research area?

I am an Infectious Diseases and Clinical Bacteriology Specialist, so I am very interested in the antibiotic prescription habit in Latin American hospitals since 2000.

What do you think about the development of open access publishing? What motivated you to do so?

The open access is very important for physicians from countries with limited resources. Is a very important possibility to achieve a globalization of the knowledge

What articles and/or books have you published recently?

Curcio D., Fernández F. Tigecycline Use in Critically Ill Older Patients: Case Reports and Critical Analysis J Am Geriatrics Soc 2007;55(2):312-3.

Curcio D., Fernández F. What is the best denominator with which to measure antibiotic consumption? Clin Microbiol Infect. 2007 May;13(5):553.

Curcio D, Fernandez F, Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Sader HS. Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
J Clin Microbiol. 2007 Jun;45(6):2095.

Curcio D, Fernandez F.. Acinetobacter spp. susceptibility to tigecycline: a worldwide perspective. J Antimicrob Chemother. 2007 Aug;60(2):449-50.

Curcio D., Fernández F., Galas M., Duret F. A combination of mathematical and statistical models to distinguish between "Susceptible" and "Resistant" clusters in the susceptibility disk diffusion method. Experien publice with Acinetobacter spp. and tigecycline. J Chemother. 2007 Aug;19(4):458-61.

Curcio D., Fernández F.,Duret F. Initial Use of Tigecycline in Argentina. Rev Chilena Infectol. 2007 Dec;24(6):497-9.

Curcio D. Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective J Clin Microbiol. 2008 May;46(5):1892-3.

Curcio D. Fernández F. Tigecycline for Acinetobacter baumannii Infections : Other Considerations. Clin Infect Dis. 2008 Jun 1;46(11):1797-8.

Stryjewski ME, Graham DR, Wilson SE, O'Riordan W, Young D, Lentnek A, Ross DP, Fowler VG, Hopkins A, Friedland HD, Barriere SL, Kitt MM, Corey GR; Assessment of Telavancin in Complicated Skin and Skin-Structure Infections Study.Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms. Clin Infect Dis. 2008 Jun 1;46(11):1683-93.

Curcio D. Tigecycline for treating bloodstream infections: a critical analysis of the available evidence. Diagn Microbiol Infect Dis. 2008 Jul;61(3):358-9;

Curcio D., Fernández F., Cané A., et al. Indications of a new antibiotic in clinical practice : results of the tigecycline initial use registry. Braz J Infect Dis 2008;12(3):198-201.

Curcio D. Fernández F . Comment on: Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp. J Antimicrob Chemother. 2008 Nov;62(5):1166-7.

Curcio D. Comment: Tigecycline treatment of Acinetobacter infections: a case series Ann Pharmacother. 2008 Nov;42(11):1717-8.

Rossi F, García P, Ronzon B, Curcio D, Dowzicky MJ. Rates of antimicrobial resistance in latin america (2004-2007) and in vitro activity of the glycylcycline tigecycline and of other antibiotics. Braz J Infect Dis. 2008 Oct;12(5):405-415.

Curcio D., Fernández F., Vergara J . et al. Late onset ventilator-associated pneumonia due to multidrug-resistant Acinetobacter spp: experience with tigecycline. J Chemother. 2009 Feb;21(1):58-62.

García P, Porte L, Curcio D. In vitro evaluation of tygecicline: Influence of Mueller-Hinton agar difusión methods and validation of E-test ® for Acinetobacter baumannii. Rev Chil Infect 2009;26(Supl 1):13-16.

Campos M, Curcio D, Seas C, et al. Tigecycline as effective as vancomycin plus aztreonam in the treatment of complicated skin and skin structure infections: Experience in Latin America. Rev Chil Infect 2009;26(Supl 1):23-31.

García P., Juliet C., Fernández A, San Martín M., Cifuentes M., Porte L., Braun S., Castillo L., Vechiola M., Tapia C., Sakurada A., Chanqueo L., Lam M., Espinoza M. y Curcio D..Estudio multicéntrico de la vigilancia de la susceptibilidad in vitro a tigeciclina en Santiago de Chile. Rev Chil Infect 2009; 26 (3): 220-226

Bantar C., Curcio D., Leal A., et al. Comparative in vitro activity of tigecycline against bacteria recovered from clinical specimens in Latin America. J Chemother. 2009 Apr;21(2):144-52.

Curcio D, Alí A, Duarte D, et al. Prescription of Antibiotics in Latin American Intensive Care Units: an Observational Study. J Chemother (in press).

Curcio D., Barcelona L., Cornistein W., et al. Current Rational to Prescribe Tigecycline: Critical Analysis of the Evidence and Usage Algorithms by an Argentinean Experts Panel. Clin Med Ther Clinical Medicine: Therapeutics 2009:1 1383-1398

Curcio D. Tigecycline in the treatment of community-acquired pneumonia. Clinical Medicine: Therapeutics 2009:1 1275-1289

Curcio D. Off-label use of antibiotics in hospitalized patients : Focus on tigecycline. J Antimicrob Chemother. 2009 Dec;64(6):1344-6.

Curcio D, Alí A, Duarte A, et al. Prescription of antibiotics in intensive care units in Latin America: an observational study. J Chemother. 2009 Nov;21(5):527-34.

Curcio D. Antibiotic stewardship: The "real world" when the resources are limited. Infect Control Hosp Epidemiol (in press)